Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Wiley Interdisciplinary Reviews. RNA
|
June 2, 2023
The tip of the iceberg-The roles of long noncoding RNAs in acute myeloid leukemia
Patrick Connerty, Richard B Lock
International Journal of Molecular Sciences
|
December 30, 2015
RNA Binding Proteins in the miRNA Pathway
Patrick Connerty, Alireza Ahadi, Gyorgy Hutvagner
Medicinal Research Reviews
|
March 31, 2026
CRISPR-Cas9 Genome-Wide Screening in Paediatric Cancer: Functional Genomics for Target Discovery and the Improvement of Existing Therapies
Steven He, Patrick Connerty, Antoine de Weck
Frontiers in Oncology
|
April 9, 2020
Long Non-coding RNAs: Major Regulators of Cell Stress in Cancer
Patrick Connerty, Richard B Lock, Charles E de Bock
Frontiers in Oncology
|
February 28, 2022
Exploring the Metabolic Landscape of AML: From Haematopoietic Stem Cells to Myeloblasts and Leukaemic Stem Cells
Yashar Mesbahi, Toby N Trahair, Richard B Lock, et al.
Biochimica Et Biophysica Acta
|
August 2, 2016
The miRNA biogenesis factors, p72/DDX17 and KHSRP regulate the protein level of Ago2 in human cells
Patrick Connerty, Sarah Bajan, Judit Remenyi, et al.
British Journal of Haematology
|
February 21, 2025
Immune-deficient MISTRG mice support expansion of leukaemia-initiating cells in xenograft models of paediatric acute myeloid leukaemia
Patrick Connerty, Jinhan Xie, Fatima El-Najjar, et al.
Pharmaceutics
|
October 23, 2021
Development of siRNA-Loaded Lipid Nanoparticles Targeting Long Non-Coding RNA LINC01257 as a Novel and Safe Therapeutic Approach for t(8;21) Pediatric Acute Myeloid Leukemia
Patrick Connerty, Ernest Moles, Charles E de Bock, et al.
British Journal of Haematology
|
June 4, 2026
The myeloid cell leukaemia-1 inhibitor MIK665 is a potent therapy in preclinical models of paediatric acute myeloid leukaemia
Patrick Connerty, John N Colgan, Fatima El-Najjar, et al.
Leukemia
|
January 10, 2019
JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis
Jennifer R Lynch, Basit Salik, Patrick Connerty, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Wiley Interdisciplinary Reviews. RNA
|
June 2, 2023
The tip of the iceberg-The roles of long noncoding RNAs in acute myeloid leukemia
Patrick Connerty, Richard B Lock
International Journal of Molecular Sciences
|
December 30, 2015
RNA Binding Proteins in the miRNA Pathway
Patrick Connerty, Alireza Ahadi, Gyorgy Hutvagner
Medicinal Research Reviews
|
March 31, 2026
CRISPR-Cas9 Genome-Wide Screening in Paediatric Cancer: Functional Genomics for Target Discovery and the Improvement of Existing Therapies
Steven He, Patrick Connerty, Antoine de Weck
Frontiers in Oncology
|
April 9, 2020
Long Non-coding RNAs: Major Regulators of Cell Stress in Cancer
Patrick Connerty, Richard B Lock, Charles E de Bock
Frontiers in Oncology
|
February 28, 2022
Exploring the Metabolic Landscape of AML: From Haematopoietic Stem Cells to Myeloblasts and Leukaemic Stem Cells
Yashar Mesbahi, Toby N Trahair, Richard B Lock, et al.
Biochimica Et Biophysica Acta
|
August 2, 2016
The miRNA biogenesis factors, p72/DDX17 and KHSRP regulate the protein level of Ago2 in human cells
Patrick Connerty, Sarah Bajan, Judit Remenyi, et al.
British Journal of Haematology
|
February 21, 2025
Immune-deficient MISTRG mice support expansion of leukaemia-initiating cells in xenograft models of paediatric acute myeloid leukaemia
Patrick Connerty, Jinhan Xie, Fatima El-Najjar, et al.
Pharmaceutics
|
October 23, 2021
Development of siRNA-Loaded Lipid Nanoparticles Targeting Long Non-Coding RNA LINC01257 as a Novel and Safe Therapeutic Approach for t(8;21) Pediatric Acute Myeloid Leukemia
Patrick Connerty, Ernest Moles, Charles E de Bock, et al.
British Journal of Haematology
|
June 4, 2026
The myeloid cell leukaemia-1 inhibitor MIK665 is a potent therapy in preclinical models of paediatric acute myeloid leukaemia
Patrick Connerty, John N Colgan, Fatima El-Najjar, et al.
Leukemia
|
January 10, 2019
JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis
Jennifer R Lynch, Basit Salik, Patrick Connerty, et al.
Page
of 2